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Many indigenous peoples are at higher risk for emerging
infectious diseases compared to other populations. This
conference panel focused on diseases of particular concern to
Native Americans (American Indians and Alaska Natives),
Australian aboriginal peoples, and the Maori of New Zealand.
Important emerging diseases among these groups include
respiratory tract infections, infections with antimicrobial-
resistant organisms, zoonotic diseases, viral hepatitis,
Helicobacter pylori and respiratory syncytial virus infections,
diseases caused by Group A and B streptococcus, tuberculosis,
and bacteremia and meningitis caused by Streptococcus
pneumoniae, Haemophilus influenzae type b, and Neisseria
meningitidis. Although the populations discussed are diverse,
they have many things in common, including a high risk for
many emerging infectious diseases, the requirement for
culturally appropriate prevention and control strategies, and
the need for increased leadership within communities of
indigenous peoples.
Native Americans
Native Americans comprise over 500 American Indian
and Alaska Native tribes of unique ethnic and anthropologic
origin. Although Native Americans account for only about 1%
of the total U.S. population, American Indians account for a
larger percentage of the population in western states, and
Alaska Natives make up 17% of persons living in Alaska.
Hospitalization rates among American Indians are 20 to
40 times greater than rates in the general U.S. population for
a number of zoonotic and vectorborne diseases, such as
hantavirus pulmonary syndrome, plague, and Rocky
Mountain spotted fever. Multiple factors may contribute to
higher risks for American Indians, but a likely explanation is
that they live in rural areas or do some type of agricultural
work, both of which increase their chance of contact with
small mammals and arthropods capable of transmitting these
diseases. Greater understanding of the transmission of these
diseases will help in the development of prevention strategies
that also preserve traditional practices.
As with hantavirus pulmonary syndrome, methicillin-
resistant Staphylococcus aureus (MRSA) infection acquired
outside of healthcare settings is an emerging infectious
disease first recognized among Native Americans. At some
rural clinics serving Natives, over 60% of S. aureus isolates
are methicillin-resistant. In one rural American Indian
community, 74% of MRSA infections could not be linked to
any of the known risk factors for MRSA such as
hospitalization within the prior year, residence in a long-term
care facility, hemodialysis, or injecting drug use.
Tuberculosis is an example of a disease that recently
reemerged, is now in decline, but continues to disproportion-
ately affect Native Americans, both in number of cases and
severity of disease. Annual incidence for Native Americans
remains twice that of the overall U.S. population, and
mortality rates are six times higher. Possible reasons for the
persistence of tuberculosis among Natives include living in
crowded households, high rates of type 2 diabetes mellitus,
and deterioration of the public health infrastructure.
The epidemiology of invasive pneumococcal disease has
been characterized for three groups of Native Americans—
Alaska Natives, members of the Navajo Nation, and White
Mountain Apaches. Rates of invasive infection among Native
American children <2 years old are some of the highest
reported in the world. Across all age groups, rates are
generally higher for Native Americans compared with those
for white or black persons in the United States. The
distributions of pneumococcal serotypes that cause invasive
disease among Navajo and Alaska Native children differ from
distributions among the total U.S. population. From 1989 to
1996, only 68% of sterile site isolates collected from Navajo
children <2 years old were serotypes in the licensed 7-valent
pneumococcal conjugate vaccine. Similarly, only 74% of
isolates from Alaska Natives <2 years old were vaccine
serotypes. This compares with 83% for non-Native children
living in Alaska and 82% for the total U.S. population. Few
studies have been conducted to determine the reason for
increased disease rates or different serotype distribution for
Native Americans. Among Alaska Native infants, group
childcare, living with someone who chews tobacco, and lack of
breastfeeding were factors associated with invasive pneumo-
coccal disease. A study of risk factors among Navajo adults is
underway.
It is not clear whether data from one Native American
group can be applied to other tribal populations. Currently, no
published data identify specific genetic factors among Native
Americans that may contribute to an increased risk of
contracting pneumococcal disease. Efforts to reduce the
burden of pneumococcal disease among Native Americans
include use of 23-valent polysaccharide vaccine in adults and
7-valent conjugate vaccine in infants, judicious antimicrobial
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drug use to limit spread of drug-resistant strains, reducing
the incidence of conditions and activities associated with
greater risk of infection (diabetes mellitus, alcohol abuse,
cigarette smoking), and support of programs to increase
knowledge about and use of protection measures against
acute respiratory infection such as breast-feeding.
Australian Aboriginal Peoples
Aboriginal peoples account for 2% of the population of
Australia. Aboriginal children have extremely high rates of
chronic suppurative otitis media (CSOM) and purulent
rhinitis. In a longitudinal study in one remote community,
60% of infants developed otorrhea by 6 months of age. As a
result, substantial hearing loss occurs in at least 20% to 25%
of school-age children and is associated with diminished
school performance. Longitudinal studies of aboriginal
infants have shown that otitis media often develops within
weeks of birth, only days after initial colonization with the
three principal bacterial pathogens S. pneumoniae,
H. influenzae, and Moraxella catarrhalis. Multiple serotypes
and molecular subtypes cocolonize infants and contribute to
persistent and progressive middle ear disease. This
multiplicity of colonizing organisms, and the high density of
colonizing bacteria in the nasopharynx, may create a vicious
cycle of inflammation in the upper airway and clinically
manifest as CSOM and purulent rhinitis. The density and
diversity of pathogens may also limit the success of
antimicrobial therapy.
Colonization by bacterial respiratory pathogens among
aboriginal children in the absence of selective pressure from
antimicrobial agents is characterized by chronic infection
from an early age. Bacterial competition, genetic exchange
among cocolonizing organisms, and limited immune
responses influence which colonizing strains dominate.
Selective pressure from antibiotics provides a window of
opportunity for resistant, “hidden” clones to become dominant
and spread among members of the community. In a study
utilizing nasopharyngeal swabs and microbiologic media,
which permitted drug-resistant and susceptible pneumococ-
cal colonies to be quantitated, densities were 2 to 3 log lower
for resistant strains compared with susceptible strains in
children not treated with antibiotics.  However, during antibiotic
treatment, the resistant strains became dominant and
remained the dominant strains for several months, providing
increased opportunity for transmission to susceptible persons.
In another aboriginal community, widespread use of
single-dose azithromycin for trachoma was followed by a
rapid increase in carriage of macrolide-resistant pneumococ-
ci. Compared with persons not colonized with pneumococci,
those colonized before use of azithromycin were at greater risk
of having macrolide-resistant strains isolated from the
nasopharyngeal specimens after azithromycin use. Similar
results may be expected from vaccine-induced immunologic
selective pressures, although the clinical impact of this
phenomenon will require careful evaluation.
Maori of New Zealand
The Maori account for approximately 16% of the
population of New Zealand. Although the health of
non-Maori, non-Pacific Polynesian children is comparable to
that of children in other western countries, poorer health
statistics, particularly for infectious diseases, are noted for
Maori children. Humanitarian government policies (Social
Security Act of 1938, free public hospitals, subsidized
housing) likely contributed to improvement in the Maori
infant mortality rate, but some disparity continues, most
likely because of fewer educational and economic opportuni-
ties. Epidemics of vaccine-preventable diseases continue
because vaccination rates are lower for the Maori than for
other residents of New Zealand. Hospitalizations for
pneumonia and bronchiolitis, mainly caused by respiratory
syncytial virus, overload the healthcare system each winter.
A continuing, 10-year clonal epidemic of Neisseria
meningitidis serogroup B disease (B4:P1.4) involving mostly
Maori and Pacific Island children (more recent immigrants to
New Zealand) highlights the importance of overcrowded
households as a factor in transmission of meningococcal
infection. Provision of more suitable yet affordable housing
may reduce transmission of meningococcal and other
infectious diseases. Preliminary data look promising that a
strain-specific vaccine may control the epidemic.
Rheumatic fever has continued to be a problem among the
Maori, as well as Pacific Island children. Prevention of
rheumatic fever is being addressed by study of an intensive
program in schools where throat swabs are collected for
culture and penicillin therapy is provided for children with
Streptococcus pyogenes.
Community Perspective and Future Directions
All too often, health research conducted among
indigenous peoples has not incorporated their local
worldview, cultural beliefs, or practices. As a result, research
questions more often reflect researchers’ interests and needs
rather than those of the community. Study designs and data
collection may have little meaning to community residents
and therefore limit scientists’ ability to obtain informed
consent and collect accurate data. Researchers may have no
sense of accountability for either the community’s or the
participant’s data, and, after data collection is complete, the
research team is never seen in the community again. Finally,
research conducted and data collected have not always been
used to bring about positive outcomes within the community
and improve the health of indigenous peoples. Thus,
community residents may feel that research is conducted on
them rather than with them.
Participation by members of indigenous communities in
research is increasing. However, to date, their contribution
is mostly limited to providing community access, assisting
with data collection, and facilitating ethical and
institutional review board approvals. To perform research
that will address the health issues of greatest concern among
indigenous peoples, increasing community involvement is
needed to select research topics, develop hypotheses and
research questions, identify optimal study designs, create
and implement data collection instruments, and analyze
and interpret data. To this end, professional development
of health researchers in indigenous communities is
imperative.
